ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $4.92M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$135.42
Trade value
$1.29M
% of position
Common Stock
Shares
−480.00
Price / share
$514.26
Trade value
$246.84K
% of position
Common Stock
Shares
−1.63K
Price / share
$515.46
Trade value
$840.20K
% of position
Common Stock
Shares
−2.39K
Price / share
$516.16
Trade value
$1.23M
% of position
Common Stock
Shares
−1.49K
Price / share
$517.11
Trade value
$768.42K
% of position
Common Stock
Shares
−1.35K
Price / share
$518.14
Trade value
$697.42K
% of position
Common Stock
Shares
−412.00
Price / share
$519.19
Trade value
$213.91K
% of position
Common Stock
Shares
−751.00
Price / share
$520.30
Trade value
$390.74K
% of position
Common Stock
Shares
−286.00
Price / share
$521.58
Trade value
$149.17K
% of position
Common Stock
Shares
−517.00
Price / share
$522.40
Trade value
$270.08K
% of position
Common Stock
Shares
−6.00
Price / share
$523.42
Trade value
$3.14K
% of position
Common Stock
Shares
−200.00
Price / share
$524.42
Trade value
$104.88K
% of position
Net shares
+0.00
Net value
-$3.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/28/2026 | M · Option Exercise | +9.50K | $135.42 | $1.29M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −480.00 | $514.26 | $246.84K | 0.1% | 333.94K | 333.46K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −1.63K | $515.46 | $840.20K | 0.5% | 333.46K | 331.83K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −2.39K | $516.16 | $1.23M | 0.7% | 331.83K | 329.45K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −1.49K | $517.11 | $768.42K | 0.5% | 329.45K | 327.96K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −1.35K | $518.14 | $697.42K | 0.4% | 327.96K | 326.62K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −412.00 | $519.19 | $213.91K | 0.1% | 326.62K | 326.20K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −751.00 | $520.30 | $390.74K | 0.2% | 326.20K | 325.45K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −286.00 | $521.58 | $149.17K | 0.1% | 325.45K | 325.17K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −517.00 | $522.40 | $270.08K | 0.2% | 325.17K | 324.65K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −6.00 | $523.42 | $3.14K | 0.0% | 324.65K | 324.64K |
| Common Stock Indirect | 8/28/2026 | S · Sale | −200.00 | $524.42 | $104.88K | 0.1% | 324.64K | 324.44K |
| Total | +0.00 | -$3.63M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
135.42
Held after
37.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 8/28/2026 | M · Option Exercise | −9.50K | 135.42 | — | 37.41K |
Common Stock
DirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.51K | Direct |
| Common Stock | 8.90K | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 166.00 | Indirect |
| Common Stock | 45.60K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |